Assessing Eligibility for Anticancer Drug Health Insurance Reimbursement Using Large Language Models: Benchmark Development and Comparative Study - Top-Institutions - MDSpire

Assessing Eligibility for Anticancer Drug Health Insurance Reimbursement Using Large Language Models: Benchmark Development and Comparative Study

  • By

  • Junhyuk Seo

  • Taerim Kim

  • Ju-Hyun Kim

  • June 15, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, New York

    Key Differentiators

    • Oncology

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, Texas

    Key Differentiators

    • Oncology

Original Source(s)

Assessing Eligibility for Anticancer Drug Health Insurance Reimbursement Using Large Language Models: Benchmark Development and Comparative Study

  • by Junhyuk Seo, Taerim Kim, Ju-Hyun Kim

  • June 15, 2026

Related Content

Correction: miR-17: from developmental regulatory hub to molecular engine driving tumourigenesis

Development and validation of a machine learning model to evaluate survival in patients with newly diagnosed breast cancer with liver metastasis

Futile Radiotherapy for Patients With Cancer Near the End of Life